Postdoc Scientist: CDK Inhibitors in ER+ Breast Cancer

Dana-Farber Cancer Institute; Boston (MA); Presencial; USD 72.000 - 76.000; Jornada completa

Descripción de la vacante

Post-doctoral position in the laboratory of Dr. Geoffrey Shapiro at the Dana-Farber Cancer Institute and Harvard Medical School.

The fellow will study CDK inhibitors in ER+ breast cancer and CDK4-dependent cancers, aiming to reverse inhibitor resistance while contributing to translational research efforts. Located in Boston, Dana-Farber is a leader in cancer research and patient care, committed to diversity, equity, and inclusion, and to publishing impactful findings and presentations.

Formación

• Ph.D./M.D.-Ph.D. with solid background in cell cycle biology and translational research.
• Demonstrated ability to complete complex research projects during Ph.D.
• Experience with CRISPR and/or drug sensitivity screens; patient‑derived xenograft models beneficial.

Responsabilidades

• Design, execute, and interpret experiments.
• Prepare scientific presentations and publications.
• Collaborate with partners and interact with collaborators.
• Supervise technicians or students as needed.

Educación

Ph.D./M.D.-Ph.D.

Herramientas

Flow cytometry

Tissue culture

PCR

Western blot

Descripción del empleo

Post-doctoral position in the laboratory of Dr. Geoffrey Shapiro at the Dana-Farber Cancer Institute and Harvard Medical School.

The fellow will study CDK inhibitors in ER+ breast cancer and CDK4-dependent cancers, aiming to reverse inhibitor resistance while contributing to translational research efforts. Located in Boston, Dana-Farber is a leader in cancer research and patient care, committed to diversity, equity, and inclusion, and to publishing impactful findings and presentations.